| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/01/2010 | WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | WO2010074123A1 Method for assaying keratan sulfate, assay kit therefor and method for detecting joint disease by using same |
| 07/01/2010 | WO2010074083A1 Immunoassay utilizing surface plasmon and fluorescence resonance energy transfer |
| 07/01/2010 | WO2010074049A1 Anti-hs6st2 antibody and use thereof |
| 07/01/2010 | WO2010073986A1 Method for evaluating resistance to skin sunburn by ultraviolet light |
| 07/01/2010 | WO2010073984A1 Method for evaluating tendency to skin pigmentation by ultraviolet light |
| 07/01/2010 | WO2010073983A1 Wrinkle formation risk evaluation method |
| 07/01/2010 | WO2010073972A1 Method for obtaining pancreatic progenitor cell using neph3 |
| 07/01/2010 | WO2010073870A1 Liver disease marker, method and apparatus for measuring same, and test method for pharmaceutical preparation |
| 07/01/2010 | WO2010073777A1 Substrate which mimics intercellular lipid of stratum corneum, and method for evaluation of skin damage using same |
| 07/01/2010 | WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody |
| 07/01/2010 | WO2010073544A1 Method for testing risk of coronary artery diseases |
| 07/01/2010 | WO2010073484A1 Acoustic wave sensor |
| 07/01/2010 | WO2010073304A1 Molten metal measuring system and probe used in the system |
| 07/01/2010 | WO2010073182A1 Assay for troponin i using magnetic labels |
| 07/01/2010 | WO2010073015A2 Peptide tag and uses thereof |
| 07/01/2010 | WO2010073014A1 Cell separation technique |
| 07/01/2010 | WO2010072969A1 Method for detecting a prion infection |
| 07/01/2010 | WO2010072881A1 Method for prospecting and identifying the characteristics of raw materials |
| 07/01/2010 | WO2010072822A2 Preparation and amplification of nucleic acids by means of magnetic particles |
| 07/01/2010 | WO2010072673A1 Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus |
| 07/01/2010 | WO2010072620A1 A cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding mehtod |
| 07/01/2010 | WO2010072581A1 Method and device for producing complex gas mixtures |
| 07/01/2010 | WO2010072410A2 Methods for immobilizing microvesicles, means and methods for detecting them, and uses thereof |
| 07/01/2010 | WO2010072383A1 Armet as a marker for cancer |
| 07/01/2010 | WO2010072349A1 Measurement apparatus for vacuum therapy systems for wound treatment |
| 07/01/2010 | WO2010072348A1 Biomarkers for inhibitors with anti-angiogenic activity |
| 07/01/2010 | WO2010072316A1 Device and method for determining soil load capacity |
| 07/01/2010 | WO2010072271A1 Device and analyzing system for conducting agglutination assays |
| 07/01/2010 | WO2010072223A1 Planar sensor |
| 07/01/2010 | WO2010072011A1 Assay device and method for performing biological assays |
| 07/01/2010 | WO2010071983A1 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators |
| 07/01/2010 | WO2010071973A1 Modification of plant phenotypes through tor gene expression |
| 07/01/2010 | WO2010052337A3 Bioanalytical procedure to detect membrane receptor activation |
| 07/01/2010 | WO2010045949A3 Apparatus and methods for analysing fluorescent particles |
| 07/01/2010 | WO2010045357A3 Enhanced on-chip sers based biomolecular detection using electrokinetically active microwells |
| 07/01/2010 | WO2010045323A3 A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage |
| 07/01/2010 | WO2010044080A3 Procedure to estimate organoleptic parameters of tissues of animal origin and device for carrying out same |
| 07/01/2010 | WO2010042669A3 Co-culture compositions and methods |
| 07/01/2010 | WO2010042284A3 Microfluidic control systems |
| 07/01/2010 | WO2010040090A3 System and method for predicting ambient temperature in a fluid analyte meter |
| 07/01/2010 | WO2010039649A3 Flavivirus-based system for production of hepatitis c virus (hcv) |
| 07/01/2010 | WO2010039247A3 Substrates with surfaces modified with peg |
| 07/01/2010 | WO2010036924A3 Inflammatory genes and microrna-21 as biomarkers for colon cancer prognosis |
| 07/01/2010 | WO2010036912A3 Capturing particles |
| 07/01/2010 | WO2010036795A3 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 07/01/2010 | WO2010033452A3 Mono-and multi-element coded libs assays and methods |
| 07/01/2010 | WO2010031047A3 Detection of vapor phase compounds by changes in physical properties of a liquid crystal |
| 07/01/2010 | WO2010030980A3 Akt and clusterin as biomarkers of chemotherapeutic responsiveness |
| 07/01/2010 | WO2010030828A3 Sonication-assisted metal-enhanced fluorescence (samef)-based bioassays |
| 07/01/2010 | WO2010028336A3 Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status |
| 07/01/2010 | WO2010028288A3 Methods for stratifying and annotating cancer drug treatment options |
| 07/01/2010 | WO2010027818A3 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use |
| 07/01/2010 | WO2010025410A3 Screening method for identifying patients at risk of adverse hepatologic events |
| 07/01/2010 | WO2010024704A4 A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof |
| 07/01/2010 | WO2010022145A3 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function |
| 07/01/2010 | WO2010019414A3 Detecting nucleic acid |
| 07/01/2010 | WO2010007391A3 Hexacyanoferrate modified electrode |
| 07/01/2010 | WO2010002478A3 Glycopeptide and uses thereof |
| 07/01/2010 | WO2009018979A9 Method for risk stratification in stable coronary artery disease |
| 07/01/2010 | US20100169995 Targeted gene disruptions in the iqgap2 gene |
| 07/01/2010 | US20100169994 Animal model |
| 07/01/2010 | US20100169992 Fgfr4 antibodies |
| 07/01/2010 | US20100169988 Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
| 07/01/2010 | US20100169987 Animal model simulating neurologic disease |
| 07/01/2010 | US20100169986 Conditional Mst Overexpressing Construct and Conditional Myostatin Overexpressing Transgenic Mouse |
| 07/01/2010 | US20100169123 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
| 07/01/2010 | US20100168538 Method and/or system for sensor artifact filtering |
| 07/01/2010 | US20100168401 Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes |
| 07/01/2010 | US20100168253 Method For Selecting Perfume Ingredient, Method For Formulating Fragrance, And Preference-Enhancing Agent |
| 07/01/2010 | US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 07/01/2010 | US20100168209 Apoptosis inducer for cancer cell |
| 07/01/2010 | US20100168084 Therapeutic compounds and related methods of use |
| 07/01/2010 | US20100168031 Lat peptides and their use in assays for identifying immunosuppressants |
| 07/01/2010 | US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/01/2010 | US20100168016 Diagnosis and treatment of diseases caused by misfolded proteins |
| 07/01/2010 | US20100168014 Screening method |
| 07/01/2010 | US20100168008 Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions |
| 07/01/2010 | US20100168006 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 07/01/2010 | US20100167980 Prolyl Endopeptidase Inhibitors For Reducing or Preventing Neutrophilic Inflammation |
| 07/01/2010 | US20100167945 Drug selection for breast cancer therapy using antibody-based arrays |
| 07/01/2010 | US20100167941 Particle based assay system |
| 07/01/2010 | US20100167940 Methods for identifying cancer risk |
| 07/01/2010 | US20100167937 Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum |
| 07/01/2010 | US20100167422 method of determining analyte concentration |
| 07/01/2010 | US20100167421 Methods for identification and prediction of multiple sclerosis disease and therapy response |
| 07/01/2010 | US20100167420 Micro Mechanical Methods and Systems for Performing Assays |
| 07/01/2010 | US20100167419 Capillary Flow Solid Phase Assay |
| 07/01/2010 | US20100167418 Stabilized low affinity conformation of integrins for drug discovery |
| 07/01/2010 | US20100167417 Long wavelength thiol-reactive fluorophores |
| 07/01/2010 | US20100167416 Novel Boronate Complex and Its Use in a Glucose Sensor |
| 07/01/2010 | US20100167414 Self-sealing microreactor and method for carrying out a reaction |
| 07/01/2010 | US20100167411 Novel slc17-type transporter protein in mammal and use thereof |
| 07/01/2010 | US20100167410 Mass-spectrometric method carried out on samples containing nucleic acids |
| 07/01/2010 | US20100167409 Solid phase extraction of alfatoxins |
| 07/01/2010 | US20100167408 Palladium(0)-Dibenzylidene Acetone Complexes |
| 07/01/2010 | US20100167407 Nickel Crucible for Melting Analytical Sample, Method of Preparing Analytical Sample and Method of Analysis |
| 07/01/2010 | US20100167406 Measuring apparatus and method for determining fluid parameters provided by a laboratory system |
| 07/01/2010 | US20100167403 Identification and selection of commercial-quality transgenic plant events |
| 07/01/2010 | US20100167397 Endocrine cell lines and method of using the same |